NovaDel Pharma, Inc

(AMEX:NVD)

Key Stats & Ratios

Valuation
Market Cap 24.28M
P/E
P/E (Trailing) -1.89
P/E (Forward)
Price/Sales 36.00
Price/Book 10.00
EPS -0.19
EPS Growth (ttm)
Fiscal Year
Fiscal Year Ends Dec 31
Last Quarter Jun 2008
Profitability
Operating Income -11268000.00
Net Income -11482000.00
Profit Margin (ttm)
Operating Margin (ttm) -35.65%
Management Effectiveness
Return on Assets (ttm) -207.30%
Return on Equity (ttm)
EBIT Margin (ttm)
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 19.57M
Revenue 316.00K
Revenue/Share 0.01
Revenue Growth (ytd) -37.20%
Annual Revenue Growth Rate (3Y) -44.95%
Annual Income Growth Rate (3Y)
Earnings Growth (ytd)
Gross Operating Profit (ttm) 875.00K
EBITDA -10358000.00
Diluted EPS (ttm) -0.19
Balance Sheet
Total Cash 2.43M
Total Cash/Share 0.04
Total Assets 5.54M
Total Liabilities 7.23M
Total Debt/Equity 1.00
Long Term Debt Common Equity Ratio 0.12
Current Ratio 1.00
Leverage Ratio 12.00
Book Value/Share 0.01
Cash Flow
Cash Flow -10923000.00
Free Cash Flow -5126000.00
Cash Flow/Share -0.18
Free Cash Flow/Share -0.08

Trading Information

Stock Price History
Beta
52Wk Change 14.30%
52Wk Change Vs. Mkt 76.00%
52Wk High 0.88
52Wk Low 0.05
10 Day Moving Average 0.35
200 Day Moving Average 0.23
Share Statistics
Average Volume 1.60M
Shares Outstanding 60.69M
Shares Float 56.52M
% Held by Insiders 6.90%
% Held by Institutions 14.50%
Shares Short (As of Dec 10, 2008) 35.13K
Short Ratio 0.20
Short % of Float 0.10%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount